• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一种新型疏水性描述符对纤维蛋白原抑制剂[[4-(4-脒基苯氧基)丁酰基]天冬氨酰]缬氨酸(FK633)衍生物进行定量构效关系研究。

Quantitative structure-activity relationship study of fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, using a novel hydrophobic descriptor.

作者信息

Tanaka A, Fujiwara H

机构信息

Basic Research Laboratories, Fujisawa Pharmaceutical Company Ltd., Yodogawa-ku, Osaka, Japan.

出版信息

J Med Chem. 1996 Dec 6;39(25):5017-20. doi: 10.1021/jm960557i.

DOI:10.1021/jm960557i
PMID:8960563
Abstract

We recently reported a novel hydrophobic descriptor for quantitative structure-activity relationship (QSAR) studies, the logarithm of the partition coefficient micelle/water (log Pmw), which is easily determined by a HPLC system and is thought to be a descriptor for a compound's affinity to a biomembrane. We carried out QSAR studies using log Pmw on the antiplatelet activities of novel fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, which resulted in a quadratic curve with a good correlation coefficient (n = 12, s = 0.368, F = 14.1**, r = 0.871), indicating that a suitable membrane affinity of the fibrinogen inhibitors is vital for their inhibitory activities. QSAR studies using STERIMOL parameters and/or CLOGP values were unsuccessful.

摘要

我们最近报道了一种用于定量构效关系(QSAR)研究的新型疏水描述符,即胶束/水分配系数的对数(log Pmw),它可以通过高效液相色谱系统轻松测定,并且被认为是化合物对生物膜亲和力的描述符。我们使用log Pmw对新型纤维蛋白原抑制剂[[4-(4-脒基苯氧基)丁酰基]天冬氨酰]缬氨酸(FK633)衍生物的抗血小板活性进行了QSAR研究,结果得到了一条具有良好相关系数的二次曲线(n = 12,s = 0.368,F = 14.1**,r = 0.871),表明纤维蛋白原抑制剂具有合适的膜亲和力对其抑制活性至关重要。使用STERIMOL参数和/或CLOGP值进行的QSAR研究未成功。

相似文献

1
Quantitative structure-activity relationship study of fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, using a novel hydrophobic descriptor.使用一种新型疏水性描述符对纤维蛋白原抑制剂[[4-(4-脒基苯氧基)丁酰基]天冬氨酰]缬氨酸(FK633)衍生物进行定量构效关系研究。
J Med Chem. 1996 Dec 6;39(25):5017-20. doi: 10.1021/jm960557i.
2
QSAR study of the peptidic fibrinogen inhibitors FK633, FR158999 and related derivatives, using a novel and useful hydrophobic descriptor (logPmw).使用一种新颖且有用的疏水性描述符(logPmw)对肽类纤维蛋白原抑制剂FK633、FR158999及相关衍生物进行定量构效关系研究。
Bioorg Med Chem Lett. 1998 Sep 22;8(18):2483-8. doi: 10.1016/s0960-894x(98)00405-3.
3
A novel and useful descriptor for hydrophobicity, partition coefficient micellar-water, and its application to a QSAR study of antiplatelet agents.一种新型且有用的疏水性描述符——胶束-水分配系数及其在抗血小板药物定量构效关系研究中的应用。
J Med Chem. 1994 Dec 23;37(26):4563-6. doi: 10.1021/jm00052a016.
4
[A new SVRDF 3D-descriptor of amino acids and its application to peptide quantitative structure activity relationship].[一种新的氨基酸SVRDF 3D描述符及其在肽定量构效关系中的应用]
Yao Xue Xue Bao. 2007 Jan;42(1):40-6.
5
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships.
J Med Chem. 1999 Aug 26;42(17):3279-88. doi: 10.1021/jm981104b.
6
Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.基于三维定量构效关系比较分子场分析/比较分子相似性指数分析模型对尿激酶型纤溶酶原激活剂抑制剂结构要求的洞察。
J Med Chem. 2006 Jan 26;49(2):475-89. doi: 10.1021/jm050149r.
7
Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.N-取代吡咯衍生物的分子模拟研究——潜在的HIV-1 gp41抑制剂
Bioorg Med Chem. 2008 Mar 15;16(6):3039-48. doi: 10.1016/j.bmc.2007.12.034. Epub 2008 Jan 28.
8
Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.选定酚类化合物的抗癌活性:使用岭回归和神经网络的定量构效关系研究
Chem Biol Drug Des. 2007 Nov;70(5):424-36. doi: 10.1111/j.1747-0285.2007.00575.x.
9
Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.新型β-硝基苯乙烯衍生物作为具有强效抗血小板活性的酪氨酸激酶抑制剂的合成与药理评价
Biochem Pharmacol. 2007 Aug 15;74(4):601-11. doi: 10.1016/j.bcp.2007.06.001. Epub 2007 Jun 3.
10
Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.新型P2Y12受体抑制剂CS-747(普拉格雷,LY640315)的活性代谢产物R-138727对人血小板聚集的立体选择性抑制作用。
Thromb Haemost. 2005 Sep;94(3):593-8. doi: 10.1160/TH05-03-0208.